Search research articles
Contact Us
Filters
Showing results (31-40 of 426) with videos related to
Page
of 43
Sort By:
Current Opinion in Neurology
|
September 28, 1999
Immunopathogenesis of multiple sclerosis: the role of T cells
G Martino, H P Hartung
Der Nervenarzt
|
February 1, 1994
[Interferon-beta in treatment of relapsing multiple sclerosis]
H P Hartung, R Hohlfeld
Brain Research
|
December 1, 1987
Leukotriene production by cultured astroglial cells
H P Hartung, K V Toyka
Advances in Experimental Medicine and Biology
|
January 1, 1997
Matrix metalloproteinases in experimental autoimmune encephalomyelitis
B C Kieseier, H P Hartung
Current Opinion in Neurology
|
June 1, 1995
The treatment of multiple sclerosis: current and future
C H Polman, H P Hartung
Der Nervenarzt
|
August 1, 1996
[Immune modulation in multiple sclerosis: linomide]
E X Weilbach, H P Hartung
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 9, 2002
Use of interferon beta in multiple sclerosis: rationale for early treatment and evidence for dose- and frequency-dependent effects on clinical response
P K Coyle, H P Hartung
European Journal of Neurology
|
January 7, 2010
Bioavailability of interferon-beta in patients with multiple sclerosis - fishing for the surrogate
B C Kieseier, H-P Hartung
Journal of Neuroimmunology
|
June 16, 2000
The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system
H P Hartung, B C Kieseier
Der Nervenarzt
|
April 1, 1995
[Cladribine in chronic progressive multiple sclerosis]
F X Weilbach, H P Hartung
Page
of 43
Search research articles
Search
Showing results (31-40 of 426) with videos related to
Sort By:
Page
of 43
Current Opinion in Neurology
|
September 28, 1999
Immunopathogenesis of multiple sclerosis: the role of T cells
G Martino, H P Hartung
Der Nervenarzt
|
February 1, 1994
[Interferon-beta in treatment of relapsing multiple sclerosis]
H P Hartung, R Hohlfeld
Brain Research
|
December 1, 1987
Leukotriene production by cultured astroglial cells
H P Hartung, K V Toyka
Advances in Experimental Medicine and Biology
|
January 1, 1997
Matrix metalloproteinases in experimental autoimmune encephalomyelitis
B C Kieseier, H P Hartung
Current Opinion in Neurology
|
June 1, 1995
The treatment of multiple sclerosis: current and future
C H Polman, H P Hartung
Der Nervenarzt
|
August 1, 1996
[Immune modulation in multiple sclerosis: linomide]
E X Weilbach, H P Hartung
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 9, 2002
Use of interferon beta in multiple sclerosis: rationale for early treatment and evidence for dose- and frequency-dependent effects on clinical response
P K Coyle, H P Hartung
European Journal of Neurology
|
January 7, 2010
Bioavailability of interferon-beta in patients with multiple sclerosis - fishing for the surrogate
B C Kieseier, H-P Hartung
Journal of Neuroimmunology
|
June 16, 2000
The role of matrix metalloproteinases in autoimmune damage to the central and peripheral nervous system
H P Hartung, B C Kieseier
Der Nervenarzt
|
April 1, 1995
[Cladribine in chronic progressive multiple sclerosis]
F X Weilbach, H P Hartung
Page
of 43